Press release
Thyroid Eye Disease Market Set for Robust Expansion Through 2034, DelveInsight Reports
To Know in detail about the Thyroid Eye Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Thyroid Eye Disease Market Forecast
https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Thyroid Eye Disease Market Report:
• The Thyroid Eye Disease market size was valued ~USD 1,993 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034).
• In September 2025, Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on improving the lives of individuals with autoimmune conditions, announced that an abstract featuring six-month off-treatment results in uncontrolled Graves' disease (GD) patients treated with batoclimab for 24 weeks will be presented at the 2025 Annual Meeting of the American Thyroid Association (ATA).
• In December 2024, Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company dedicated to developing best-in-class therapies for rare and serious conditions, has reported positive topline results from its Phase 3 THRIVE-2 clinical trial. The study evaluated veligrotug (veli), an intravenous (IV) anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, in patients with chronic thyroid eye disease (TED). TED is an autoimmune disorder marked by inflammation, tissue expansion, and damage in the areas surrounding and behind the eyes.
• In 2022, the United States held the largest market share for Thyroid Eye Disease among the 7MM, with a valuation of around USD 1.98 billion. This figure is projected to grow further by 2034.
• Among the pipeline therapies, three notable drugs-Viridian Therapeutics' VRDN-001, Immunovant Sciences' batoclimab, and Novartis' COSENTYX (secukinumab)-are poised to make a substantial impact on expanding the Thyroid Eye Disease market.
• In 2022, the United States reported approximately 1,012,000 prevalent cases of thyroid eye disease.
• In 2022, the United States represented the largest share of thyroid eye disease cases, comprising approximately 42% of the total population across the 7MM. Germany contributed around 13%, while Japan accounted for about 8% of the total population share.
• In 2022, Germany had the highest number of thyroid eye disease cases among the EU4 countries, followed by France, while Spain recorded the fewest cases.
• DelveInsight estimates that in 2022, Japan had approximately 16,300 cases of acute Thyroid Eye Disease and 41,900 cases of chronic Thyroid Eye Disease. These numbers are expected to rise over the forecast period.
• Key Thyroid Eye Disease Companies: Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharmaceuticals, ValenzaBio, ACELYRIN Inc., Horizon Therapeutics USA, Inc., Neothetics, Inc, Sling Therapeutics, Inc., Novartis, and others
• Key Thyroid Eye Disease Therapies: Batoclimab (IMVT 1401), COSENTYX (secukinumab), VRDN-001, Linsitinib, Aflibercept, VB421, RVT-140, lonigutamab, Teprotumumab, LIPO-102, Linsitinib, CFZ533, and others
• The Thyroid Eye Disease epidemiology based on gender analyzed that the incidence of Thyroid Eye Disease is 16 per 100,000 females and 2.9 per 100,000 males with an approximate prevalence of 0.25% with no significant ethnic predisposition
• The Thyroid Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Thyroid Eye Disease pipeline products will significantly revolutionize the Thyroid Eye Disease market dynamics.
Thyroid Eye Disease Overview
A complex orbital inflammatory condition that can be sight-threatening, incapacitating, and disfiguring is known as thyroid eye disease (TED). In honour of Robert J. Graves, an Irish doctor who first identified thyrotoxicosis in a woman presenting with goitre, rapid heartbeat, and exophthalmos, TED is also known as Graves' ophthalmopathy.
Get a Free sample for the Thyroid Eye Disease Market Report
https://www.delveinsight.com/report-store/thyroid-eye-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Thyroid Eye Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Thyroid Eye Disease Epidemiology Segmentation:
The Thyroid Eye Disease market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Thyroid Eye Disease
• Prevalent Cases of Thyroid Eye Disease by severity
• Gender-specific Prevalence of Thyroid Eye Disease
• Diagnosed Cases of Episodic and Chronic Thyroid Eye Disease
Download the report to understand which factors are driving Thyroid Eye Disease epidemiology trends @ Thyroid Eye Disease Epidemiology Forecast
https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Thyroid Eye Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Thyroid Eye Disease market or expected to get launched during the study period. The analysis covers Thyroid Eye Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Thyroid Eye Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Thyroid Eye Disease Therapies and Key Companies
• Batoclimab (IMVT 1401): Immunovant Sciences
• COSENTYX (secukinumab): Novartis
• VRDN-001: Viridian Therapeutics
• Linsitinib: Sling Therapeutics
• Aflibercept: Regeneron Pharmaceuticals
• VB421: ValenzaBio
• Secukinumab: Novartis
• RVT-1401: Immunovant Sciences GmbH
• lonigutamab: ACELYRIN Inc.
• Teprotumumab: Horizon Therapeutics USA, Inc.
• LIPO-102: Neothetics, Inc
• Linsitinib: Sling Therapeutics, Inc.
• CFZ533: Novartis
Discover more about therapies set to grab major Thyroid Eye Disease market share @ Thyroid Eye Disease Treatment Market
https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Thyroid Eye Disease Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Thyroid Eye Disease Companies: Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharmaceuticals, ValenzaBio, ACELYRIN Inc., Horizon Therapeutics USA, Inc., Neothetics, Inc, Sling Therapeutics, Inc., Novartis, and others
• Key Thyroid Eye Disease Therapies: Batoclimab (IMVT 1401), COSENTYX (secukinumab), VRDN-001, Linsitinib, Aflibercept, VB421, RVT-140, lonigutamab, Teprotumumab, LIPO-102, Linsitinib, CFZ533, and others
• Thyroid Eye Disease Therapeutic Assessment: Thyroid Eye Disease current marketed and Thyroid Eye Disease emerging therapies
• Thyroid Eye Disease Market Dynamics: Thyroid Eye Disease market drivers and Thyroid Eye Disease market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Thyroid Eye Disease Unmet Needs, KOL's views, Analyst's views, Thyroid Eye Disease Market Access and Reimbursement
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Eye Disease Market Set for Robust Expansion Through 2034, DelveInsight Reports here
News-ID: 4188753 • Views: …
More Releases from DelveInsight Business Research
Sjogren's Syndrome Pipeline 2025: Detailed Clinical Trials and FDA-Approved Ther …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sjogren's Syndrome pipeline constitutes 20+ key companies continuously working towards developing 22+ Sjogren's Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Sjogren's Syndrome Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sjogren's Syndrome Market.
The Sjogren's…
Hyperoxaluria Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evalua …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hyperoxaluria pipeline constitutes 6+ key companies continuously working towards developing 6+ Hyperoxaluria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Hyperoxaluria Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
Epidermolysis Bullosa Market Growth to Surge During Forecast Period (2024-2034), …
The Epidermolysis Bullosa market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Epidermolysis Bullosa pipeline products will significantly revolutionize the Epidermolysis Bullosa market dynamics.
DelveInsight's "Epidermolysis Bullosa Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Epidermolysis Bullosa, historical and forecasted epidemiology as well as the Epidermolysis Bullosa market trends in the United…
Chronic Rhinosinusitis with Nasal Polyps Market to Witness Promising Upswing by …
DelveInsight's "Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Rhinosinusitis with Nasal Polyps, historical and forecasted epidemiology as well as the Chronic Rhinosinusitis with Nasal Polyps market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Chronic Rhinosinusitis with Nasal Polyps market outlook, drug uptake, treatment…
More Releases for Thyroid
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Thyroid Function Test Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for thyroid function tests has witnessed substantial growth in the past few years. The market is projected to expand from $1.7 billion in 2024 to $1.81 billion in 2025, with an…
Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test …
The Thyroid Function Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Thyroid Function Test Market Size During the Forecast Period?
The thyroid function test market has grown significantly in recent years. It is expected to grow from $1.7 billion in 2024…
Thyroid Function Test Market Report 2024 - Thyroid Function Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global Thyroid Function Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period.
Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive…
Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view…
